perindopril has been researched along with Diabetes Mellitus, Adult-Onset in 130 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (7.69) | 18.2507 |
| 2000's | 57 (43.85) | 29.6817 |
| 2010's | 54 (41.54) | 24.3611 |
| 2020's | 9 (6.92) | 2.80 |
| Authors | Studies |
|---|---|
| Belenkov, YN; Danilogorskaya, YA; Ilgisonis, IS; Kozhevnikova, MV; Lishuta, AS; Privalova, EA; Zektser, VY; Zheleznykh, EA | 1 |
| Borghi, C; Cicero, AFG; D'Addato, S; Fogacci, F; Giovannini, M; Rizzoli, E | 1 |
| Tchernev, G | 1 |
| Chalmers, J; Hamet, P; Harrap, S; Lee, AK; Marre, M; Mcevoy, JW; Ohkuma, T; Selvin, E; Sharrett, AR; Wang, D; Warren, B; Williams, B; Woodward, M | 1 |
| Cooper, ME; Knudsen, ST | 1 |
| Chalmers, J; Cooper, M; Harrap, S; Mancia, G; Ohkuma, T; Poulter, N; Tian, J; Wang, JG; Woodward, M; Zoungas, S | 1 |
| Belenkov, YN; Danilogorskaya, YA; Khabarova, NV; Kozhevnikova, MV; Lishuta, AS; Privalova, EA; Shakaryants, GA; Shchendrigina, AA; Zektser, VY; Zheleznykh, EA | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Jun, M; Kim, H; Mancia, G; Marre, M; Poulter, NR; Rebholz, CM; Selvin, E; Wang, D; Woodward, M; Zoungas, S | 1 |
| Brzozowska-Villatte, R; De Champvallins, M; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y | 1 |
| Chalmers, J; Colagiuri, S; Cooper, M; Harrap, S; Mancia, G; Marre, M; Mohammedi, K; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Lévy, BI; Taddei, S | 1 |
| Chalmers, J; Colagiuri, S; Cooper, ME; DeVries, JH; Grobbee, DE; Hamet, P; Li, Q; Mancia, G; Marre, M; van Steen, SC; Williams, B; Woodward, M | 1 |
| Chalmers, J; Coresh, J; Herrington, W; Li, Q; Mancia, G; Marre, M; Mohammedi, K; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
| Statsenko, ME; Titarenko, MN; Turkina, SV | 1 |
| Ramirez, AJ; Sanchez, MJ; Sanchez, RA | 1 |
| Chalmers, J; Cooper, ME; Glasziou, P; Hamet, P; Harrap, S; Jun, M; Mancia, G; Marre, M; Neal, B; Ohkuma, T; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Hamet, P; Harrap, S; Mancia, G; Marre, M; McEvoy, JW; Muntner, P; Ohkuma, T; Rahman, F; Rodgers, A; Selvin, E; Williams, B; Woodward, M | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M | 1 |
| van der Merwe, WM | 1 |
| Dehayem, MY; Etoa, M; Hamadou, B; Kaze, FF; Kengne, AP; Kouam, M; Mbanya, JC; Mfeukeu-Kuate, L; Nganou-Gnindjio, CN; Ngassam, E; Nkamgna, A; Sobngwi, E; Tankeu, AT | 1 |
| Kang, LN; Li, QL; Sun, JY; Xie, J; Xu, B; Ye, JX; Zhai, L | 1 |
| Chalmers, J; Cooper, ME; Mancia, G; Marre, M; Morton, J; Ng, MK; Poulter, NR; Woodward, M; Zoungas, S | 1 |
| Davis, SN; Konig, M; Lamos, EM; Stein, SA | 1 |
| Barbarash, OL; Cherniavskaia, EIu; Zvereva, TN | 1 |
| Bischoff, A | 1 |
| Bhadada, SV; Patel, BM | 1 |
| Arima, H; Chalmers, J; Harrap, S; Hirakawa, Y; Mancia, G; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Bakris, GL; Yamout, H | 1 |
| Gorbat, TV; Netchessova, TA; Shepelkevich, AP | 1 |
| Sharma, K; Sweiss, N | 1 |
| Farsang, C | 1 |
| Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Arima, H; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Mancia, G; Ninomiya, T; Poulter, N; Woodward, M; Zoungas, S | 1 |
| Arima, H; Billot, L; Chalmers, J; Colagiuri, S; Cooper, ME; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Hirakawa, Y; Joshi, R; Li, Q; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Matthews, DR; Mogensen, CE; Monaghan, H; Neal, B; Patel, A; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Glasziou, P; Grobbee, DE; Hamet, P; Kengne, AP; MacMahon, S; Poulter, N; van der Graaf, Y; van der Leeuw, J; Visseren, FL; Woodward, M; Zoungas, S | 1 |
| Kanorskiĭ, SG | 1 |
| Ruilope, LM | 1 |
| Chalmers, J; Cooper, M; Grobbee, R; Hirakawa, Y; Jardine, M; Kengne, AP; Matthews, DR; Patel, A; Poulter, N; Woodward, M; Zoungas, S | 1 |
| Pichler, G; Redon, J | 2 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Heller, S; Li, Q; MacMahon, S; Mancia, G; Marre, M; Matthews, D; Neal, B; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Wong, MG; Woodward, M; Zoungas, S | 1 |
| Hatala, R; Hatalova, K; Pella, D; Sidlo, R | 1 |
| Ostroumova, OD; Zykova, AA | 1 |
| Chalmers, J; Harrap, S; Hirakawa, Y; Lisheng, L; Mancia, G; Marre, M; Mohammedi, K; Neal, B; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Grobbee, DE; Harrap, S; Heller, S; Mancia, G; Marre, M; Poulter, N; van der Graaf, Y; van der Leeuw, J; Visseren, FL; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Harrap, S; Li, Q; Marre, M; Mohammedi, K; Patel, A; Woodward, M; Zoungas, S | 1 |
| Karpov, YA | 1 |
| Atkins, ER; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Lees, K; Liu, L; Mancia, G; Marre, M; Perkovic, V; Poulter, N; Rodgers, A; Salam, A; Williams, B; Woodward, M | 1 |
| Grimaldi, A; Katsahian, S; Laurent, S; Molle, D; Tropeano, AI | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Chalmers, J; Joshi, R; Kengne, AP; MacMahon, S | 1 |
| Cass, A; Chalmers, J; Cooper, M; de Galan, BE; Glasziou, P; Grobbee, DE; Hamet, P; Harrap, S; MacMahon, S; Mancia, G; Marre, M; Mogensen, CE; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Williams, B; Woodward, M | 1 |
| Zannad, F | 1 |
| Bi, Y; Billot, L; Bompoint, S; Chalmers, J; Joshi, R; Kengne, AP; Ninomiya, T; Patel, A | 1 |
| Askerov, MM | 1 |
| Poulter, NR | 1 |
| Beulens, JW; Cruickshank, JK; Grobbee, DE; Hughes, AD; Lu, J; McG Thom, SA; Patel, A; Stanton, A; Stolk, RP; Vingerling, JR | 1 |
| Cass, A; Chalmers, J; de Galan, BE; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| Anderson, C; Chalmers, J; Cooper, M; de Galan, BE; Dufouil, C; Grobbee, DE; Hackett, M; Hamet, P; Heller, SR; Lisheng, L; MacMahon, S; Mancia, G; Neal, B; Pan, CY; Patel, A; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| de la Sierra, A; Ruilope, LM; Waeber, B | 1 |
| Buniatian, ND; Lednev, OA; Sergeev, SV; Zaslavskaia, RM | 1 |
| Chalmers, J; Colagiuri, S; Grobbee, DE; Hamet, P; Heller, S; Kengne, AP; Marre, M; Neal, B; Pan, CY; Patel, A; Woodward, M; Zoungas, S | 1 |
| Cass, A; Chalmers, J; Cooper, M; Grobbee, D; Hamet, P; Harrap, S; Liu, L; MacMahon, S; Mancia, G; Mogensen, CE; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Cass, A; Chalmers, J; Cooper, M; Grobbee, DE; Heerspink, HJ; Mancia, G; Mogensen, CE; Neal, B; Ninomiya, T; Perkovic, V; Woodward, M; Zoungas, S | 1 |
| Ghiadoni, L | 1 |
| Cheng, SS; Li, HL; Li, J; Li, X; Yuan, L | 1 |
| Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
| Batty, GD; Chalmers, J; Czernichow, S; de Galan, BE; Hamet, P; Harrap, SB; Huxley, R; Li, Q; Neal, B; Patel, A; Poulter, N; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Colagiuri, S; Grobbee, DE; Hamet, P; Heller, S; Kengne, AP; Lievre, M; Marre, M; Neal, B; Patel, A; Travert, F; Woodward, M; Zoungas, S | 1 |
| Koya, D | 1 |
| Chalmers, J; Heller, S; Januszewicz, A; Joshi, P; Liu, L; Neal, B; Pan, C; Patel, A; Poulter, N; Tandon, N; Woodward, M; Zoungas, S | 1 |
| Hamet, P | 1 |
| Nedogoda, SV | 1 |
| Beulens, JW; Chalmers, J; Cooper, ME; Grobbee, DE; Harrap, S; Kengne, AP; Mancia, G; Neal, B; Patel, A; Poulter, N; van der Schouw, YT; van Dieren, S; Woodward, M; Zoungas, S | 1 |
| Drouet, C; Graffin, B; Hosotte, M; Kanny, G; Landy, C; Millot, I; Nadaud, J; Plancade, D; Ragot, C | 1 |
| Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 1 |
| Cao, G; DeRosa, G; Forcada, P; Pagano, P; Piorno, P; Rivas, C; Toblli, JE | 1 |
| De Leeuw, PW; Erdogan, G; Halimi, S; Hamani, A; Hess, B; Jermendy, G; Luger, A; Mechmeche, R; Mogensen, CE; Nolan, J; Ribeiro, A; Ritz, E; Ruilope, L; Rull, J; Sanchez, R; Sareli, P; Scheen, A; Sirotiakova, J; Taton, J; Thomas, SM; Viberti, G; Widimsky, J | 1 |
| Chalmers, J | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R; Mugellini, A | 1 |
| McDonald, D; McKenna, K; Moore, KB; Thompson, CJ; Tormey, WP | 1 |
| Laurent, S | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R | 1 |
| Javorský, M; Kalina, I; Kozárová, M; Salagovic, J; Tkác, I; Tkácová, R | 1 |
| Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; O'Brien, RC; Raffaele, J; Tsalamandris, C | 1 |
| Foussas, S; Gavras, H; Gavras, I; Iraklianou, S; Manolis, AJ; Pittaras, A; Psaltiras, G; Psomali, D; Tsioufis, K; Zaris, M | 1 |
| Boasquevisque, EM; de Lourdes Rodrigues, M; Francischetti, EA; Genelhu, V; Ismerim, VL; Matos, JP | 1 |
| Waeber, B | 2 |
| De Simone, C; Famularo, G; Minisola, G; Nicotra, GC | 1 |
| Ciliberti, P; Graziosi, M; Rapezzi, C; Riva, L | 1 |
| Balkestein, E; Boutouyrie, P; Joannides, R; Katsahian, S; Laloux, B; Laurent, S; Pannier, B; Struijker-Boudier, H; Thuillez, C; Tropeano, AI | 1 |
| Ruilope, LM; Segura, J | 1 |
| Chalmers, J; Joshi, R; Patel, A; Perkovic, V | 1 |
| Cordonnier, DJ; Gilbert, RE; Gow, RM; Kelly, DJ; Langham, RG; Pinel, N; Zaoui, P; Zhang, Y | 1 |
| De la Figuera von Wichmann, M; Llisterri Caro, JL | 1 |
| Bompoint, S; Chalmers, J; Joshi, R; Patel, A; Perkovic, V | 1 |
| Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
| Chalmers, J; Joshi, R; Kengne, AP; Patel, A; Perkovic, V | 1 |
| Kaplan, NM | 1 |
| Billot, L; Chalmers, J; Cooper, M; Glasziou, P; Grobbee, DE; Hamet, P; Harrap, S; Heller, S; Liu, LS; MacMahon, S; Mancia, G; Marre, M; Mogensen, CE; Neal, B; Pan, CY; Patel, A; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
| Leye, A; Marre, M | 1 |
| Einecke, D | 1 |
| Arfanakis, DA; Chlouverakis, G; Karkavitsas, NS; Kochiadakis, GE; Koukouraki, S; Marketou, ME; Stathaki, MI; Vardas, PE; Zacharis, EA | 1 |
| Bakris, GL; Duka, I | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Nagy, V | 1 |
| Dunstan, E | 1 |
| Procopiou, M | 1 |
| Feihl, F; Heim, A; Waeber, B | 1 |
| Chalmers, J; Joshi, R; Patel, A | 1 |
| Bakris, GL; Berkwits, M | 1 |
| Hönl, SB | 1 |
| Bijlstra, PJ; Lutterman, JA; Smits, P; Thien, T | 1 |
| Overlack, A; Stumpe, KO | 1 |
| Abraham, AA; Michaelis, OE; Scalbert, E; Striffler, JS; Thibault, N; Velasquez, MT | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R | 1 |
| Chen, J; He, R; Xia, H | 1 |
| Bhathena, SJ; Campbell, JD; Hansen, CT; Michaelis, OE; Scalbert, E; Striffler, JS; Thibault, N; Velasquez, MT | 1 |
| Casiraghi, F; Gambara, V; Mosconi, L; Remuzzi, A; Remuzzi, G; Ruggenenti, P; Sangalli, F | 1 |
| Barro, C; Bilous, RW; Cordonnier, DJ; Halimi, S; Hurault de Ligny, B; Maynard, M; Pinel, N; Reznic, Y; Simon, D; Zaoui, P | 1 |
| Ha, SK; Ho Shin, J; Hun Kim, D; Jung Kim, S; Rae Kim, K; Su Park, H; Suk Han, D; Yong Lee, S; Yung Lee, H | 1 |
| Lee, YJ; Tsai, JC | 1 |
| Bilous, RW; Cordonnier, DJ; Pinel, N; White, KE | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Bak, JF; Gerdes, LU; Pedersen, O; Sørensen, NS | 1 |
| Depoorter, JC; Herbaut, C; Jandrain, B; Voorde, KV | 1 |
18 review(s) available for perindopril and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Kidney Diseases; Observational Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2020 |
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Metabolic Syndrome; Middle Aged; Obesity; Perindopril; Treatment Outcome | 2021 |
Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
Topics: Antihypertensive Agents; Blood Circulation; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2018 |
An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Perindopril; United Kingdom | 2013 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
[ADVANCE-ON Trial; How to Achieve Maximum Reduction of Mortality in Patients With Type 2 Diabetes].
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Survival Rate | 2015 |
Implications of the ADVANCE study for clinical practice.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Humans; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2009 |
What matters in ADVANCE and ADVANCE-ON.
Topics: Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Incidence; Indapamide; Kidney Failure, Chronic; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Multiple Organ Failure; Perindopril; Treatment Outcome | 2003 |
[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Time Factors | 2005 |
Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Topics: Albuminuria; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2006 |
Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Vascular Diseases | 2006 |
[Overview of cardiovascular risk factors].
Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Perindopril; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking Prevention; Spain; Vasodilator Agents | 2006 |
New insights from ADVANCE.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Internationality; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2007 |
Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Models, Biological; Perindopril | 2007 |
[The prevention of the hypertension related damage in type-2 diabetes: the first step of the ADVANCE trial].
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
67 trial(s) available for perindopril and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Topics: Adult; Aged; Body-Weight Trajectory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypertension; Indapamide; Life Style; Male; Middle Aged; Obesity; Overweight; Perindopril; Risk Factors; Weight Gain; Weight Loss | 2020 |
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Gliclazide; Glycated Hemoglobin; Glycemic Control; Heart Disease Risk Factors; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Prognosis; Risk Factors; Treatment Outcome | 2020 |
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; beta 2-Microglobulin; Biomarkers; Cause of Death; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Indapamide; Male; Middle Aged; Outcome Assessment, Health Care; Perindopril; Risk Factors; Vascular Diseases | 2020 |
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Glycosylation; Hemoglobins; Humans; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Proportional Hazards Models; Risk; Treatment Outcome; Vascular Diseases | 2018 |
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Indapamide; Kidney; Kidney Diseases; Male; Middle Aged; Obesity; Overweight; Perindopril; Reference Values; Renal Insufficiency | 2018 |
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Monitoring; Female; Humans; Indapamide; Male; Medication Therapy Management; Middle Aged; Perindopril; Risk Assessment; Treatment Outcome; Withholding Treatment | 2019 |
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Global Health; Humans; Incidence; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Survival Rate; Treatment Outcome | 2019 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2019 |
Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2019 |
Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Chemokine CXCL12; Diabetes Mellitus, Type 2; Endothelial Cells; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Prognosis; Prospective Studies; Stem Cells; Vascular Endothelial Growth Factor A | 2013 |
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
Topics: Australia; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Indapamide; Male; Middle Aged; Neoplasms; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2013 |
[Effect of perindopril on the processes of subclinical inflammation in patients with arterial hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arterial Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Inflammation; Male; Middle Aged; Perindopril; Treatment Outcome; Vasodilation | 2013 |
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models | 2014 |
Efficacy of single-pill perindopril/indapamide in patients with hypertension and type 2 diabetes.
Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Incidence; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2014 |
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Myocardial Infarction; Perindopril; Retrospective Studies; Risk Reduction Behavior; Stroke | 2014 |
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cause of Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Office Visits; Perindopril; Risk Factors | 2014 |
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Risk Factors | 2014 |
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Perindopril; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Perindopril; Treatment Outcome | 2016 |
Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Tetrazoles | 2016 |
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Endpoint Determination; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Male; Middle Aged; Perindopril; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors | 2016 |
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disease Progression; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Perindopril; Pulse; Risk Factors; Stroke | 2016 |
Lowering of brachial pulse pressure in 9379 hypertensives with type 2 diabetes and reduction of cardiovascular events.
Topics: Antihypertensive Agents; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Indapamide; Male; Middle Aged; Multivariate Analysis; Perindopril; Prospective Studies; Risk Factors; Treatment Outcome | 2008 |
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom | 2008 |
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension, Renal; Indapamide; Male; Middle Aged; Perindopril; Placebos; Treatment Outcome | 2008 |
Lowering blood pressure reduces renal events in type 2 diabetes.
Topics: Age of Onset; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Indapamide; Male; Perindopril; Systole | 2009 |
[Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2009 |
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril | 2009 |
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Placebos | 2009 |
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Models, Biological; Patient Selection; Perindopril; Risk; Risk Assessment; Risk Factors | 2010 |
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Placebos | 2010 |
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension, Renovascular; Indapamide; Male; Middle Aged; Myocardial Infarction; Perindopril; Renal Insufficiency, Chronic; Stroke; Treatment Outcome | 2010 |
Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril | 2010 |
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Asia; Australasia; Blood Glucose; Canada; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Disease Progression; Diuretics; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Incidence; Indapamide; Male; Middle Aged; Models, Cardiovascular; Perindopril; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors | 2011 |
Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy.
Topics: Aged; Diabetes Mellitus, Type 2; Diastole; Electrocardiography; Female; Heart Ventricles; Humans; Indapamide; Male; Middle Aged; Perindopril; Placebos | 2011 |
[Lowering blood pressure and glucose reduces renal events in type 2 diabetes; ADVANCE study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Diuretics; Humans; Indapamide; Perindopril | 2010 |
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial.
Topics: Aged; Asia; Australia; Blood Glucose; Canada; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Europe; Europe, Eastern; Female; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Male; Middle Aged; New Zealand; Perindopril; Proportional Hazards Models | 2011 |
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Odds Ratio; Perindopril; Risk Factors; Treatment Outcome | 2012 |
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Cough; Diabetes Mellitus, Type 2; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2003 |
[ADVANCE study: objectives, design and current status].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Vascular Diseases | 2003 |
The albuminuric action of atrial natriuretic peptide is not modified by ACE-inhibition with perindopril in Type 2 diabetes.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Male; Middle Aged; Perindopril | 2003 |
A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Perindopril; Tetrazoles | 2003 |
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies | 2004 |
Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Blood Pressure; Cardiovascular Diseases; Compliance; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Male; Middle Aged; Perindopril; Treatment Outcome | 2005 |
Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2005 |
Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brachial Artery; Carotid Arteries; Diabetes Complications; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Single-Blind Method; Tunica Intima; Tunica Media | 2006 |
ADVANCE: breaking new ground in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril | 2006 |
Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA Primers; Female; Gene Expression Regulation; Humans; Kidney; Male; Middle Aged; Perindopril; Phosphorylation; Polymerase Chain Reaction; RNA; Smad2 Protein; Transforming Growth Factor beta | 2006 |
ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Dropouts; Perindopril; Risk; Systole; Treatment Outcome | 2006 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
Vascular outcome in type 2 diabetes: an ADVANCE?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Treatment Outcome | 2007 |
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2007 |
Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Perindopril; Statistics, Nonparametric; Sympathetic Nervous System | 2008 |
[Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Indapamide; Male; Middle Aged; Perindopril; Placebos; Prospective Studies; Survival Rate; Treatment Outcome | 2007 |
[ADVANCE: a morbidity mortality study of diabetes and hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Humans; Hypertension; Indapamide; Middle Aged; Perindopril | 2008 |
A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome | 1993 |
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Leg; Male; Middle Aged; Perindopril; Platelet Aggregation; Propanolamines; Reference Values; Regional Blood Flow; Rheology; Vascular Resistance | 1998 |
[Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria].
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Indoles; Kidney; Middle Aged; Perindopril; Renal Plasma Flow | 1996 |
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Cross-Over Studies; Dextrans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Indoles; Kidney Glomerulus; Male; Middle Aged; Nitrendipine; Particle Size; Perindopril; Renal Circulation | 1999 |
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Biopsy, Needle; Confidence Intervals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Immunohistochemistry; Indoles; Kidney Cortex; Kidney Function Tests; Male; Middle Aged; Perindopril; Prognosis; Prospective Studies; Treatment Outcome | 1999 |
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 2001 |
Does ACE inhibition slow progression of glomerulopathy in patients with Type 2 diabetes mellitus?
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Glomerulus; Microscopy, Electron; Middle Aged; Perindopril; Placebos; Proteinuria | 2001 |
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1 | 2002 |
Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Indoles; Insulin; Lipids; Male; Middle Aged; Perindopril | 1992 |
45 other study(ies) available for perindopril and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
To study the dynamics of serum levels of vascular remodeling in patients with hypertension, including in combination with type 2 diabetes mellitus during 12‑month therapy with perindopril A.
Topics: Diabetes Mellitus, Type 2; Humans; Hypertension; Perindopril; Tissue Inhibitor of Metalloproteinase-1; Vascular Remodeling | 2022 |
Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Blood Pressure; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Perindopril | 2022 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |
[Vasoprotective Effects of Prolonged Therapy With Perindopril A in Patients with Hypertension Including Concomitant Type 2 Diabetes Mellitus].
Topics: Arteries; Blood Pressure; Diabetes Mellitus, Type 2; Humans; Hyperemia; Hypertension; Perindopril | 2020 |
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Microvessels; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2017 |
[Influence of Therapy With Fixed Combination of Perindopril and Amlodipine on Parameters of Elasticity of Main Vessels and Microcirculation in Patients With Arterial Hypertension and Type 2 Diabetes Mellitus].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Elasticity; Humans; Hypertension; Microcirculation; Middle Aged; Perindopril; Pulse Wave Analysis | 2018 |
Diabetic patients with essential hypertension treated with amlodipine: blood pressure and arterial stiffness effects of canagliflozin or perindopril.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Essential Hypertension; Female; Humans; Male; Middle Aged; Perindopril; Sodium-Glucose Transporter 2 Inhibitors; Vascular Stiffness | 2019 |
Utility of fixed-dose single tablet antihypertensive drug combinations in Cameroonians with type 2 diabetes and newly diagnosed hypertension.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Tablets | 2019 |
[Cardiorenal continuum. Nephro- and cardioprotection with perindopril/indapamide therapy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardio-Renal Syndrome; Cause of Death; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Indapamide; Perindopril; Sodium Chloride Symporter Inhibitors; Survival Analysis | 2013 |
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Metoprolol; Perindopril; Ramipril; Rats, Wistar; Spironolactone | 2014 |
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
Topics: Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Indapamide; Male; Perindopril | 2014 |
Efficacy and tolerability of fixed-dose combination of perindopril/indapamide in type 2 diabetes mellitus: PICASSO trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prediabetic State; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Health Status Indicators; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors | 2016 |
Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2016 |
[The Results of Long-Term Observation of Patients Who Participated in the ADVANCE Trial].
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2015 |
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Precision Medicine; Risk Factors; Risk Reduction Behavior | 2016 |
Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2017 |
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Hypotension; Indapamide; Male; Medication Adherence; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stroke | 2017 |
Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic | 2009 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Educational Status; Female; Gliclazide; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Mental Status Schedule; Myocardial Infarction; Perindopril; Risk Factors; Stroke | 2009 |
[Use of prestarium (perindopril) in patients with polymorbidity syndrome (AH, DM, nephropathy)].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Treatment Outcome | 2009 |
Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet.
Topics: Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Glucose; Caspase 3; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Interleukin-1beta; Ion Channels; Islets of Langerhans; Male; Mitochondrial Proteins; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Telmisartan; Uncoupling Protein 2 | 2013 |
[Atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atrial Fibrillation; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Neuropathies; Drug Monitoring; Female; Heart Conduction System; Heart Failure, Diastolic; Humans; Male; Middle Aged; Perindopril; Random Allocation; Secondary Prevention; Sotalol; Thioctic Acid; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
[Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2011 |
Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Bradykinin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypertension; Laryngeal Diseases; Male; Perindopril; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunoassay; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System; von Willebrand Factor | 2002 |
Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Heart; Hypertension; Indapamide; Male; Myocardium; Obesity; Perindopril; Rats; Rats, Zucker; Ventricular Function, Left | 2003 |
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Perindopril; Tetrazoles; Treatment Outcome | 2003 |
Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Glycated Hemoglobin; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking | 2003 |
What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Administration Schedule; Drug Combinations; Heart Diseases; Humans; Hypertension; Indapamide; Kidney Diseases; Perindopril | 2005 |
Idiosyncratic pancreatitis associated with perindopril.
Topics: Aged; Amylases; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Pancreatitis; Perindopril; Treatment Outcome | 2005 |
[Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Time Factors | 2007 |
Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vascular Diseases | 2007 |
The ADVANCE trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Humans; Indapamide; Perindopril | 2008 |
The ADVANCE trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Perindopril; Ramipril; Randomized Controlled Trials as Topic | 2008 |
Advances in reducing the burden of vascular disease in type 2 diabetes.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Middle Aged; Perindopril | 2008 |
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2008 |
[Results of ADVANCE trial conducted in type 2 diabetic patients].
Topics: Cardiovascular Diseases; Congresses as Topic; Diabetes Mellitus, Type 2; Drug Combinations; Europe; Humans; Indapamide; Microcirculation; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Societies, Medical; Survival Rate | 2008 |
[Type 2 diabetes. Routine ACE inhibitors?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Forearm; Humans; Indoles; Injections, Intra-Arterial; Insulin Resistance; Male; Methacholine Chloride; Middle Aged; Nitroprusside; Perindopril; Regional Blood Flow; Vasodilation | 1995 |
Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Kidney Glomerulus; Kidney Tubules; Male; Obesity; Perindopril; Rats; Rats, Inbred SHR; Reserpine; Time Factors | 1997 |
Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Glycogen; Heart; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR | 1998 |
ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Diabetes Mellitus, Type 2; Drug Resistance; Genotype; Humans; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Proteinuria | 2000 |
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Comorbidity; Cough; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Prevalence; Proteinuria; Receptor, Bradykinin B2; Receptors, Bradykinin; Sex Distribution; Taiwan | 2001 |
Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indoles; Lipids; Male; Middle Aged; Perindopril; Time Factors | 1992 |